SCHEMBL6347994

SCHEMBL6347994

CN(c1ccc(Cl)cc1)S(=O)(=O)c1ccc(C(=O)Nc2ccc([N+](=O)[O-])cc2C(=O)O)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNK2 O95069 1/20 0.52
KCNK10 P57789 1/20 0.52
AKR1C4 P17516 1/20 0.52
AKR1C3 P42330 1/20 0.52
AKR1C2 P52895 1/20 0.52
AKR1C1 Q04828 1/20 0.52
KDM4E B2RXH2 2/20 0.52
MAPK1 P28482 1/20 0.52
HTT P42858 1/20 0.52
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
SMN1; SMN2 Q16637 1/20 0.48
ATM Q13315 1/20 0.48
MAPT P10636 3/20 0.48
ALDH1A1 P00352 1/20 0.48
ALB P02768 1/20 0.47
ERO1A Q96HE7 1/20 0.47
SERPINE1 P05121 1/20 0.47
SIRT2 Q8IXJ6 4/20 0.46
HSD17B10 Q99714 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6360161 0.91 SIRT2 (0.59) AKR1C4AKR1C3AKR1C2AKR1C1HTT
SCHEMBL6351360 0.85 METAP2 (0.55) KCNK2KCNK10AKR1C2AKR1C1KDM4E
SCHEMBL6349554 0.84 AKR1C2 (0.48) AKR1C4AKR1C3AKR1C2AKR1C1KDM4E
SCHEMBL6358696 0.83 SIRT2 (0.63) KDM4EMAPK1HTTMEN1KMT2A
SCHEMBL6358917 0.79 ALB (0.54) KDM4EHTTMEN1KMT2ASMN1; SMN2
SCHEMBL6357252 0.78 SIRT2 (0.65) AKR1C4AKR1C3AKR1C2AKR1C1HTT
SCHEMBL13802485 0.77 SERPINE1 (0.59) KCNK2KCNK10AKR1C4AKR1C3AKR1C2
SCHEMBL6349003 0.77 SIRT2 (0.49) AKR1C4AKR1C3AKR1C2AKR1C1KDM4E
SCHEMBL6711828 0.76 SLC10A6 (0.52) KDM4EMAPK1HTTSMN1; SMN2MAPT
SCHEMBL6347687 0.76 METAP2 (0.50) AKR1C4AKR1C3AKR1C2AKR1C1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113450-A1 Antibacterial agents PHARMACIA & UPJOHN COMPANY 2005-05-26 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113450-A1 Antibacterial agents CLPP, SPOUT1, SAMHD1 KCNK2 4133/4885KCNK10 3271/4885AKR1C4 3065/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.